Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Phase Diagrams of Polymer-Dispersed Liquid Crystal Systems of Itraconazole/Component Immiscibility Induced by Molecular Anisotropy.

Kozyra A, Mugheirbi NA, Paluch KJ, Garbacz G, Tajber L.

Mol Pharm. 2018 Nov 5;15(11):5192-5206. doi: 10.1021/acs.molpharmaceut.8b00724. Epub 2018 Oct 10.

PMID:
30252481
2.

Gastric Emptying and Small Bowel Water Content after Administration of Grapefruit Juice Compared to Water and Isocaloric Solutions of Glucose and Fructose: A Four-Way Crossover MRI Pilot Study in Healthy Subjects.

Grimm M, Koziolek M, Saleh M, Schneider F, Garbacz G, Kühn JP, Weitschies W.

Mol Pharm. 2018 Feb 5;15(2):548-559. doi: 10.1021/acs.molpharmaceut.7b00919. Epub 2018 Jan 18.

PMID:
29298479
3.

Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form.

Haznar-Garbacz D, Kaminska E, Zakowiecki D, Lachmann M, Kaminski K, Garbacz G, Dorożyński P, Kulinowski P.

AAPS PharmSciTech. 2018 Feb;19(2):951-960. doi: 10.1208/s12249-017-0912-0. Epub 2017 Nov 2.

PMID:
29098644
4.

A novel mechanical antrum model for the prediction of the gastroretentive potential of dosage forms.

Neumann M, Schneider F, Koziolek M, Garbacz G, Weitschies W.

Int J Pharm. 2017 Sep 15;530(1-2):63-70. doi: 10.1016/j.ijpharm.2017.07.067. Epub 2017 Jul 24.

PMID:
28750896
5.

The improvement of the dissolution rate of ziprasidone free base from solid oral formulations.

Zakowiecki D, Cal K, Kaminski K, Adrjanowicz K, Swinder L, Kaminska E, Garbacz G.

AAPS PharmSciTech. 2015 Aug;16(4):922-33. doi: 10.1208/s12249-015-0285-1. Epub 2015 Jan 16.

6.

Dissolution of mesalazine modified release tablets under standard and bio-relevant test conditions.

Garbacz G, Rappen GM, Koziolek M, Weitschies W.

J Pharm Pharmacol. 2015 Feb;67(2):199-208. doi: 10.1111/jphp.12332. Epub 2014 Dec 31.

PMID:
25557626
7.

Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System.

Koziolek M, Grimm M, Becker D, Iordanov V, Zou H, Shimizu J, Wanke C, Garbacz G, Weitschies W.

J Pharm Sci. 2015 Sep;104(9):2855-63. doi: 10.1002/jps.24274. Epub 2014 Nov 19.

PMID:
25411065
8.

Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting.

Drechsler M, Garbacz G, Thomann R, Schubert R.

Eur J Pharm Biopharm. 2014 Nov;88(3):807-15. doi: 10.1016/j.ejpb.2014.09.006. Epub 2014 Oct 6.

PMID:
25301294
9.

Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets.

Eisenächer F, Garbacz G, Mäder K.

Eur J Pharm Biopharm. 2014 Nov;88(3):778-86. doi: 10.1016/j.ejpb.2014.07.009. Epub 2014 Jul 31.

PMID:
25086221
10.

Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI.

Koziolek M, Grimm M, Garbacz G, Kühn JP, Weitschies W.

Mol Pharm. 2014 May 5;11(5):1632-9. doi: 10.1021/mp500022u. Epub 2014 Apr 15.

PMID:
24697247
11.

Development of pressure-sensitive dosage forms with a core liquefying at body temperature.

Wilde L, Bock M, Wolf M, Glöckl G, Garbacz G, Weitschies W.

Eur J Pharm Biopharm. 2014 Apr;86(3):507-13. doi: 10.1016/j.ejpb.2013.12.008. Epub 2013 Dec 17.

PMID:
24361536
12.

Development of a pressure-sensitive glyceryl tristearate capsule filled with a drug-containing hydrogel.

Wilde L, Bock M, Glöckl G, Garbacz G, Weitschies W.

Int J Pharm. 2014 Jan 30;461(1-2):296-300. doi: 10.1016/j.ijpharm.2013.11.062. Epub 2013 Dec 11.

PMID:
24333906
13.

Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions.

Garbacz G, Kandzi A, Koziolek M, Mazgalski J, Weitschies W.

AAPS PharmSciTech. 2014 Feb;15(1):230-6. doi: 10.1208/s12249-013-0050-2. Epub 2013 Dec 3.

14.

A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.

Garbacz G, Kołodziej B, Koziolek M, Weitschies W, Klein S.

Eur J Pharm Sci. 2014 Jan 23;51:224-31. doi: 10.1016/j.ejps.2013.09.020. Epub 2013 Oct 3.

PMID:
24095865
15.

Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach.

Koziolek M, Görke K, Neumann M, Garbacz G, Weitschies W.

Eur J Pharm Sci. 2014 Jun 16;57:250-6. doi: 10.1016/j.ejps.2013.09.004. Epub 2013 Sep 16.

PMID:
24051217
16.

Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.

Garbacz G, Cadé D, Benameur H, Weitschies W.

Eur J Pharm Sci. 2014 Jun 16;57:264-72. doi: 10.1016/j.ejps.2013.08.039. Epub 2013 Sep 8.

PMID:
24021609
17.

Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution.

Koziolek M, Garbacz G, Neumann M, Weitschies W.

Mol Pharm. 2013 Jun 3;10(6):2211-21. doi: 10.1021/mp300607e. Epub 2013 May 8. Review.

PMID:
23654347
18.

Simulating the postprandial stomach: physiological considerations for dissolution and release testing.

Koziolek M, Garbacz G, Neumann M, Weitschies W.

Mol Pharm. 2013 May 6;10(5):1610-22. doi: 10.1021/mp300604u. Epub 2013 Apr 1. Review.

PMID:
23506381
19.

An automated system for monitoring and regulating the pH of bicarbonate buffers.

Garbacz G, Kołodziej B, Koziolek M, Weitschies W, Klein S.

AAPS PharmSciTech. 2013 Jun;14(2):517-22. doi: 10.1208/s12249-013-9933-5. Epub 2013 Mar 7.

20.

The role of individual gastric emptying of pellets in the prediction of diclofenac in vivo dissolution.

Klein S, Garbacz G, Pišlar M, Locatelli I, Liu C, Weitschies W, Siegmund W, Mrhar A, Bogataj M.

J Control Release. 2013 Mar 28;166(3):286-93. doi: 10.1016/j.jconrel.2012.12.032. Epub 2013 Jan 8.

PMID:
23306025

Supplemental Content

Loading ...
Support Center